A02415 Summary:

BILL NOA02415
 
SAME ASNo Same As
 
SPONSORPaulin (MS)
 
COSPNSRSteck, Gottfried, Rosenthal L, Simotas, Zebrowski, Pellegrino
 
MLTSPNSRCook, Perry, Titone, Walker
 
Amd §§3216, 3221 & 4303, Ins L
 
Mandates insurance companies to provide coverage for non-experimental infertility treatments; provides that coverage shall not be required to include the diagnosis and treatment of infertility in connection with the reversal of elective sterilizations, sex change procedures, cloning or medical or surgical services or procedures that are deemed to be experimental; provides the superintendent of financial services in consultation with the commissioner of the department of health shall determine infertility for purposes of coverage.
Go to top    

A02415 Actions:

BILL NOA02415
 
01/20/2017referred to insurance
01/03/2018referred to insurance
06/21/2018enacting clause stricken
Go to top

A02415 Committee Votes:

Go to top

A02415 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

A02415 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          2415
 
                               2017-2018 Regular Sessions
 
                   IN ASSEMBLY
 
                                    January 20, 2017
                                       ___________
 
        Introduced  by  M.  of  A. PAULIN, STECK, GOTTFRIED, ROSENTHAL, SIMOTAS,
          ZEBROWSKI -- Multi-Sponsored by -- M. of A. COOK, PERRY, TITONE, WALK-
          ER -- read once and referred to the Committee on Insurance
 
        AN ACT to amend the insurance law, in relation  to  mandating  insurance
          companies  to provide coverage for non-experimental infertility treat-
          ments
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.  Paragraph  13  of  subsection  (i) of section 3216 of the
     2  insurance law, as added by chapter 897 of the laws of  1990  and  renum-
     3  bered by chapter 131 of the laws of 1992, is amended to read as follows:
     4    (13)  (A) Every policy which provides coverage for hospital care shall
     5  not exclude coverage for hospital care for diagnosis  and  treatment  of
     6  correctable  medical  conditions  otherwise covered by the policy solely
     7  because the medical condition results in infertility[.]; provided howev-
     8  er that:
     9    (i) Subject to the provisions of subparagraph (C) of  this  paragraph,
    10  in  no  case  shall such coverage exclude surgical or medical procedures
    11  provided as part of such hospital care which would correct malformation,
    12  disease or dysfunction resulting in infertility; and
    13    (ii) Provided, further however, that  subject  to  the  provisions  of
    14  subparagraph  (C)  of  this  paragraph,  in  no case shall such coverage
    15  exclude diagnostic tests and procedures provided as part of such  hospi-
    16  tal  care that are necessary to determine infertility or that are neces-
    17  sary  in  connection  with  any  surgical  or  medical   treatments   or
    18  prescription  drug coverage provided pursuant to this paragraph, includ-
    19  ing such diagnostic tests and procedures as hysterosalpingogram, hyster-
    20  oscopy, endometrial biopsy, laparoscopy, sono-hysterogram,  post  coital
    21  tests, testis biopsy, semen analysis, blood tests, ultrasound, ovulation
    22  induction, intrauterine insemination, in-vitro fertilization, intracyto-
    23  plasmic  sperm injection, uterine embryo lavage, embryo transfer, gamete
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD06452-01-7

        A. 2415                             2
 
     1  intra-fallopian transfer, zygote  intra-fallopian  transfer,  low  tubal
     2  ovum transfer, donor eggs, and donor sperm; and
     3    (iii)  Provided,  further  however,  every  such policy which provides
     4  coverage for prescription drugs shall  include,  within  such  coverage,
     5  coverage  for  prescription  drugs approved by the federal Food and Drug
     6  Administration for use in the diagnosis and treatment of infertility  in
     7  accordance with subparagraph (C) of this paragraph.
     8    (B) Every policy which provides coverage for surgical and medical care
     9  shall  not  exclude coverage for surgical and medical care for diagnosis
    10  and treatment of correctable medical conditions otherwise covered by the
    11  policy solely because the medical condition results  in  infertility[.];
    12  provided, however that:
    13    (i)  Subject  to the provisions of subparagraph (C) of this paragraph,
    14  in no case shall such coverage exclude surgical  or  medical  procedures
    15  provided as part of such hospital care which would correct malformation,
    16  disease or dysfunction resulting in infertility; and
    17    (ii)  Provided,  further  however,  that  subject to the provisions of
    18  subparagraph (C) of this paragraph,  in  no  case  shall  such  coverage
    19  exclude  diagnostic tests and procedures provided as part of such hospi-
    20  tal care that are necessary to determine infertility or that are  neces-
    21  sary   in   connection  with  any  surgical  or  medical  treatments  or
    22  prescription drug coverage provided pursuant to this paragraph,  includ-
    23  ing such diagnostic tests and procedures as hysterosalpingogram, hyster-
    24  oscopy,  endometrial  biopsy, laparoscopy, sono-hysterogram, post coital
    25  tests, testis biopsy, semen analysis, blood tests, ultrasound, ovulation
    26  induction, intrauterine insemination, in-vitro fertilization, intracyto-
    27  plasmic sperm injection, uterine embryo lavage, embryo transfer,  gamete
    28  intra-fallopian  transfer,  zygote  intra-fallopian  transfer, low tubal
    29  ovum transfer, donor eggs, and donor sperm; and
    30    (iii) Provided, further however,  every  such  policy  which  provides
    31  coverage  for  prescription  drugs  shall include, within such coverage,
    32  coverage for prescription drugs approved by the federal  Food  and  Drug
    33  Administration  for use in the diagnosis and treatment of infertility in
    34  accordance with subparagraph (C) of this paragraph.
    35    (C)  Coverage  of  diagnostic  and  treatment  procedures,   including
    36  prescription  drugs,  used in the diagnosis and treatment of infertility
    37  as required by subparagraphs (A) and (B)  of  this  paragraph  shall  be
    38  provided in accordance with the provisions of this subparagraph.
    39    (i) Coverage shall be provided for persons whose ages range from twen-
    40  ty-one  through  forty-four  years of age, provided that nothing in this
    41  subparagraph shall preclude the provision of coverage to  persons  whose
    42  age is below or above such range.
    43    (ii)  Diagnosis  and  treatment  of infertility shall be prescribed as
    44  part of a physician's overall plan  of  care  and  consistent  with  the
    45  guidelines for coverage as referenced in this subparagraph.
    46    (iii)  Coverage may be subject to co-payments, coinsurance and deduct-
    47  ibles as may be deemed appropriate by  the  superintendent  and  as  are
    48  consistent  with  those  established  for  other benefits within a given
    49  policy.
    50    (iv) Coverage shall be limited to  those  individuals  who  have  been
    51  previously covered under the policy for a period of not less than twelve
    52  months,  provided  that for the purposes of this subparagraph "period of
    53  not less than twelve months" shall be  determined  by  calculating  such
    54  time from either the date the insured was first covered under the exist-
    55  ing policy or from the date the insured was first covered by a previous-
    56  ly in-force converted policy, whichever is earlier.

        A. 2415                             3
 
     1    (v) Coverage shall not be required to include the diagnosis and treat-
     2  ment of infertility in connection with:
     3    (I) The reversal of elective sterilizations;
     4    (II) Sex change procedures;
     5    (III) cloning; or
     6    (IV)  Medical or surgical services or procedures that are deemed to be
     7  experimental in accordance with clinical guidelines referenced in clause
     8  (vi) of this subparagraph.
     9    (vi) The superintendent, in  consultation  with  the  commissioner  of
    10  health,  shall  promulgate  regulations which shall stipulate the guide-
    11  lines and standards which shall be used in carrying out  the  provisions
    12  of this subparagraph, which shall include:
    13    (I)  The  determination of "infertility" in accordance with the stand-
    14  ards and guidelines established and adopted by the American  College  of
    15  Obstetricians  and  Gynecologists and the American Society for Reproduc-
    16  tive Medicine;
    17    (II) The identification of experimental procedures and treatments  not
    18  covered  for  the  diagnosis  and treatment of infertility determined in
    19  accordance with the standards and guidelines established and adopted  by
    20  the American College of Obstetricians and Gynecologists and the American
    21  Society for Reproductive Medicine;
    22    (III)  The  identification  of  the  required training, experience and
    23  other standards for health care providers for the  provision  of  proce-
    24  dures  and  treatments  for  the  diagnosis and treatment of infertility
    25  determined in accordance with the standards and  guidelines  established
    26  and  adopted  by the American College of Obstetricians and Gynecologists
    27  and the American Society for Reproductive Medicine; and
    28    (IV) The determination of appropriate medical candidates by the treat-
    29  ing physician in accordance with the  standards  and  guidelines  estab-
    30  lished and adopted by the American College of Obstetricians and Gynecol-
    31  ogists and/or the American Society for Reproductive Medicine.
    32    (vii)  A  policy  providing coverage under this paragraph may have the
    33  following requirements and limitations:
    34    (I) Limit coverage for in-vitro fertilization, gamete  intra-fallopian
    35  transfer, zygote intra-fallopian transfer and low tubal ovum transfer to
    36  those individuals who have been unable to conceive or produce conception
    37  or  sustain  a successful pregnancy through less expensive and medically
    38  viable infertility treatment or procedures covered under such a policy;
    39    (II) Nothing in this subsection shall be construed to deny the  cover-
    40  age  required by this section to any individual who forgoes a particular
    41  infertility treatment or procedure if the individual's physician  deter-
    42  mines that such a treatment or procedure is likely to be unsuccessful;
    43    (III) Limit coverage to a lifetime cap of one hundred thousand dollars
    44  for  ovulation induction, intrauterine insemination, in-vitro fertiliza-
    45  tion, intracytoplasmic sperm injection, uterine  embryo  lavage,  embryo
    46  transfer, gamete intra-fallopian transfer, zygote intra-fallopian trans-
    47  fer, low tubal ovum transfer, donor eggs, and donor sperm;
    48    (IV)  Require  disclosure  by  the individual seeking such coverage to
    49  such individual's existing health  insurance  carrier  of  any  previous
    50  infertility  treatment  or procedures for which such individual received
    51  coverage under a different  health  insurance  policy.  Such  disclosure
    52  shall be made on a form and in the manner prescribed by the commissioner
    53  of the department of financial services.
    54    §  2.  Subparagraphs (A), (B) and (C) of paragraph 6 of subsection (k)
    55  of section 3221 of the insurance law, as amended by section 1 of part  K
    56  of chapter 82 of the laws of 2002, are amended to read as follows:

        A. 2415                             4
 
     1    (A)  Every  group  policy  issued  or  delivered  in  this state which
     2  provides coverage for hospital  care  shall  not  exclude  coverage  for
     3  hospital  care for diagnosis and treatment of correctable medical condi-
     4  tions [otherwise covered by  the  policy]  solely  because  the  medical
     5  condition results in infertility; provided, however that:
     6    (i)  subject  to the provisions of subparagraph (C) of this paragraph,
     7  in no case shall such coverage exclude surgical  or  medical  procedures
     8  provided as part of such hospital care which would correct malformation,
     9  disease or dysfunction resulting in infertility; and
    10    (ii)  provided,  further  however,  that  subject to the provisions of
    11  subparagraph (C) of this paragraph,  in  no  case  shall  such  coverage
    12  exclude  diagnostic tests and procedures provided as part of such hospi-
    13  tal care that are necessary to determine infertility or that are  neces-
    14  sary   in   connection  with  any  surgical  or  medical  treatments  or
    15  prescription drug coverage provided pursuant to this paragraph,  includ-
    16  ing such diagnostic tests and procedures as hysterosalpingogram, hyster-
    17  oscopy,  endometrial  biopsy, laparoscopy, sono-hysterogram, post coital
    18  tests, testis biopsy, semen analysis,  blood  tests  [and],  ultrasound,
    19  ovulation  induction, intrauterine insemination, in-vitro fertilization,
    20  intracytoplasmic sperm injection, uterine embryo lavage,  embryo  trans-
    21  fer,  gamete  intra-fallopian transfer, zygote intra-fallopian transfer,
    22  low tubal ovum transfer, donor eggs, and donor sperm; and
    23    (iii) provided, further however,  every  such  policy  which  provides
    24  coverage  for  prescription  drugs  shall include, within such coverage,
    25  coverage for prescription drugs approved by the federal  Food  and  Drug
    26  Administration  for use in the diagnosis and treatment of infertility in
    27  accordance with subparagraph (C) of this paragraph.
    28    (B) Every group  policy  issued  or  delivered  in  this  state  which
    29  provides coverage for surgical and medical care shall not exclude cover-
    30  age for surgical and medical care for diagnosis and treatment of correc-
    31  table  medical  conditions  [otherwise  covered  by  the  policy] solely
    32  because the medical condition results in infertility; provided,  however
    33  that:
    34    (i)  subject  to the provisions of subparagraph (C) of this paragraph,
    35  in no case shall such coverage exclude surgical  or  medical  procedures
    36  which  would  correct  malformation, disease or dysfunction resulting in
    37  infertility; and
    38    (ii) provided, further however, that  subject  to  the  provisions  of
    39  subparagraph  (C)  of  this  paragraph,  in  no case shall such coverage
    40  exclude diagnostic tests and procedures that are necessary to  determine
    41  infertility  or  that  are  necessary in connection with any surgical or
    42  medical treatments or prescription drug coverage  provided  pursuant  to
    43  this  paragraph,  including  such  diagnostic  tests  and  procedures as
    44  hysterosalpingogram,  hysteroscopy,  endometrial  biopsy,   laparoscopy,
    45  sono-hysterogram,  post  coital  tests,  testis  biopsy, semen analysis,
    46  blood tests [and], ultrasound, ovulation induction, intrauterine insemi-
    47  nation,  in-vitro  fertilization,  intracytoplasmic   sperm   injection,
    48  uterine embryo lavage, embryo transfer, gamete intra-fallopian transfer,
    49  zygote  intra-fallopian  transfer,  low tubal ovum transfer, donor eggs,
    50  and donor sperm; and
    51    (iii) provided, further however,  every  such  policy  which  provides
    52  coverage  for  prescription  drugs  shall include, within such coverage,
    53  coverage for prescription drugs approved by the federal  Food  and  Drug
    54  Administration  for use in the diagnosis and treatment of infertility in
    55  accordance with subparagraph (C) of this paragraph.

        A. 2415                             5
 
     1    (C)  Coverage  of  diagnostic  and  treatment  procedures,   including
     2  prescription  drugs,  used in the diagnosis and treatment of infertility
     3  as required by subparagraphs (A) and (B)  of  this  paragraph  shall  be
     4  provided in accordance with the provisions of this subparagraph.
     5    (i) Coverage shall be provided for persons whose ages range from twen-
     6  ty-one  through  forty-four  years,  provided  that nothing herein shall
     7  preclude the provision of coverage to persons  whose  age  is  below  or
     8  above such range.
     9    (ii)  Diagnosis  and  treatment  of infertility shall be prescribed as
    10  part of a physician's overall plan  of  care  and  consistent  with  the
    11  guidelines for coverage as referenced in this subparagraph.
    12    (iii)  Coverage may be subject to co-payments, coinsurance and deduct-
    13  ibles as may be deemed appropriate by  the  superintendent  and  as  are
    14  consistent  with  those  established  for  other benefits within a given
    15  policy.
    16    (iv) Coverage shall be limited to  those  individuals  who  have  been
    17  previously covered under the policy for a period of not less than twelve
    18  months,  provided  that for the purposes of this subparagraph "period of
    19  not less than twelve months" shall be  determined  by  calculating  such
    20  time from either the date the insured was first covered under the exist-
    21  ing policy or from the date the insured was first covered by a previous-
    22  ly in-force converted policy, whichever is earlier.
    23    (v) Coverage shall not be required to include the diagnosis and treat-
    24  ment  of  infertility  in  connection with: (I) [in vitro fertilization,
    25  gamete intrafallopian  tube  transfers  or  zygote  intrafallopian  tube
    26  transfers;  (II)]  the reversal of elective sterilizations; [(III)] (II)
    27  sex change procedures; [(IV)] (III) cloning; or [(V)]  (IV)  medical  or
    28  surgical  services  or  procedures that are deemed to be experimental in
    29  accordance with clinical guidelines referenced in clause  (vi)  of  this
    30  subparagraph.
    31    (vi)  The  superintendent,  in  consultation  with the commissioner of
    32  health, shall promulgate regulations which shall  stipulate  the  guide-
    33  lines  and  standards which shall be used in carrying out the provisions
    34  of this subparagraph, which shall include:
    35    (I) The determination of "infertility" in accordance with  the  stand-
    36  ards  and  guidelines established and adopted by the American College of
    37  Obstetricians and Gynecologists and the American Society  for  Reproduc-
    38  tive Medicine;
    39    (II)  The identification of experimental procedures and treatments not
    40  covered for the diagnosis and treatment  of  infertility  determined  in
    41  accordance  with the standards and guidelines established and adopted by
    42  the American College of Obstetricians and Gynecologists and the American
    43  Society for Reproductive Medicine;
    44    (III) The identification of  the  required  training,  experience  and
    45  other  standards  for  health care providers for the provision of proce-
    46  dures and treatments for the  diagnosis  and  treatment  of  infertility
    47  determined  in  accordance with the standards and guidelines established
    48  and adopted by the American College of Obstetricians  and  Gynecologists
    49  and the American Society for Reproductive Medicine; and
    50    (IV) The determination of appropriate medical candidates by the treat-
    51  ing  physician  in  accordance  with the standards and guidelines estab-
    52  lished and adopted by the American College of Obstetricians and Gynecol-
    53  ogists and/or the American Society for Reproductive Medicine.
    54    (vii) A policy providing coverage under this paragraph  may  have  the
    55  following requirements and limitations:

        A. 2415                             6
 
     1    (I)  Limit coverage for in-vitro fertilization, gamete intra-fallopian
     2  transfer, zygote intra-fallopian transfer and low tubal ovum transfer to
     3  those individuals who have been unable to conceive or produce conception
     4  or sustain a successful pregnancy through less expensive  and  medically
     5  viable infertility treatment or procedures covered under such a policy;
     6    (II)  Nothing in this subsection shall be construed to deny the cover-
     7  age required by this section to any individual who forgoes a  particular
     8  infertility  treatment or procedure if the individual's physician deter-
     9  mines that such a treatment or procedure is likely to be unsuccessful;
    10    (III) Limit coverage to a lifetime cap of one hundred thousand dollars
    11  for ovulation induction, intrauterine insemination, in-vitro  fertiliza-
    12  tion,  intracytoplasmic  sperm  injection, uterine embryo lavage, embryo
    13  transfer, gamete intra-fallopian transfer, zygote intra-fallopian trans-
    14  fer, low tubal ovum transfer, donor eggs, and donor sperm;
    15    (IV) Require disclosure by the individual  seeking  such  coverage  to
    16  such  individual's  existing  health  insurance  carrier of any previous
    17  infertility treatment or procedures for which such  individual  received
    18  coverage  under  a  different  health  insurance policy. Such disclosure
    19  shall be made on a form and in the manner prescribed by the commissioner
    20  of the department of financial services.
    21    § 3. Paragraphs 1, 2 and 3 of subsection (s) of section  4303  of  the
    22  insurance  law,  as  amended by section 2 of part K of chapter 82 of the
    23  laws of 2002, are amended to read as follows:
    24    (1) A hospital service corporation or health service corporation which
    25  provides coverage for hospital  care  shall  not  exclude  coverage  for
    26  hospital  care for diagnosis and treatment of correctable medical condi-
    27  tions [otherwise covered by  the  policy]  solely  because  the  medical
    28  condition results in infertility; provided, however that:
    29    (A)  subject  to the provisions of paragraph three of this subsection,
    30  in no case shall such coverage exclude surgical  or  medical  procedures
    31  provided as part of such hospital care which would correct malformation,
    32  disease or dysfunction resulting in infertility; and
    33    (B) provided, further however, that subject to the provisions of para-
    34  graph  three  of this subsection, in no case shall such coverage exclude
    35  diagnostic tests and procedures provided as part of such  hospital  care
    36  that  are  necessary  to  determine infertility or that are necessary in
    37  connection with any surgical or medical treatments or prescription  drug
    38  coverage provided pursuant to this subsection, including such diagnostic
    39  tests  and  procedures as hysterosalpingogram, hysteroscopy, endometrial
    40  biopsy, laparoscopy, sono-hysterogram, post coital tests, testis biopsy,
    41  semen analysis, blood  tests  [and],  ultrasound,  ovulation  induction,
    42  intrauterine   insemination,  in-vitro  fertilization,  intracytoplasmic
    43  sperm injection, uterine embryo lavage, embryo transfer,  gamete  intra-
    44  fallopian  transfer,  zygote  intra-fallopian  transfer,  low tubal ovum
    45  transfer, donor eggs, and donor sperm; and
    46    (C) provided, further however, every such policy which provides cover-
    47  age for prescription drugs shall include, within such coverage, coverage
    48  for prescription drugs approved by the federal Food  and  Drug  Adminis-
    49  tration for use in the diagnosis and treatment of infertility in accord-
    50  ance with paragraph three of this subsection.
    51    (2)  A  medical  expense indemnity or health service corporation which
    52  provides coverage for surgical and medical care shall not exclude cover-
    53  age for surgical and medical care for diagnosis and treatment of correc-
    54  table medical conditions otherwise covered by the policy solely  because
    55  the medical condition results in infertility; provided, however that:

        A. 2415                             7

     1    (A)  subject  to the provisions of paragraph three of this subsection,
     2  in no case shall such coverage exclude surgical  or  medical  procedures
     3  which  would  correct  malformation, disease or dysfunction resulting in
     4  infertility; and
     5    (B) provided, further however, that subject to the provisions of para-
     6  graph  three  of this subsection, in no case shall such coverage exclude
     7  diagnostic tests and procedures that are necessary to  determine  infer-
     8  tility  or that are necessary in connection with any surgical or medical
     9  treatments or prescription  drug  coverage  provided  pursuant  to  this
    10  subsection,  including  such diagnostic tests and procedures as hystero-
    11  salpingogram, hysteroscopy, endometrial biopsy, laparoscopy, sono-hyste-
    12  rogram, post coital tests, testis biopsy, semen  analysis,  blood  tests
    13  [and],   ultrasound,  ovulation  induction,  intrauterine  insemination,
    14  in-vitro fertilization, intracytoplasmic sperm injection, uterine embryo
    15  lavage, embryo transfer, gamete intra-fallopian transfer, zygote  intra-
    16  fallopian  transfer,  low  tubal  ovum  transfer,  donor eggs, and donor
    17  sperm; and
    18    (C) provided, further however, every such policy which provides cover-
    19  age for prescription drugs shall include, within such coverage, coverage
    20  for prescription drugs approved by the federal Food  and  Drug  Adminis-
    21  tration for use in the diagnosis and treatment of infertility in accord-
    22  ance with paragraph three of this subsection.
    23    (3)   Coverage  of  diagnostic  and  treatment  procedures,  including
    24  prescription drugs used in the diagnosis and treatment of infertility as
    25  required by paragraphs one and two of this subsection shall be  provided
    26  in accordance with this paragraph.
    27    (A) Coverage shall be provided for persons whose ages range from twen-
    28  ty-one  through  forty-four  years,  provided  that nothing herein shall
    29  preclude the provision of coverage to persons  whose  age  is  below  or
    30  above such range.
    31    (B) Diagnosis and treatment of infertility shall be prescribed as part
    32  of a physician's overall plan of care and consistent with the guidelines
    33  for coverage as referenced in this paragraph.
    34    (C)  Coverage  may  be subject to co-payments, coinsurance and deduct-
    35  ibles as may be deemed appropriate by  the  superintendent  and  as  are
    36  consistent  with  those  established  for  other benefits within a given
    37  policy.
    38    (D) Coverage shall be limited  to  those  individuals  who  have  been
    39  previously covered under the policy for a period of not less than twelve
    40  months,  provided that for the purposes of this paragraph "period of not
    41  less than twelve months" shall be determined by  calculating  such  time
    42  from  either  the  date the insured was first covered under the existing
    43  policy or from the date the insured was first covered  by  a  previously
    44  in-force converted policy, whichever is earlier.
    45    (E) Coverage shall not be required to include the diagnosis and treat-
    46  ment  of  infertility  in  connection with: (i) [in vitro fertilization,
    47  gamete intrafallopian  tube  transfers  or  zygote  intrafallopian  tube
    48  transfers;  (ii)]  the reversal of elective sterilizations; [(iii)] (ii)
    49  sex change procedures; [(iv)] (iii) cloning; or [(v)]  (iv)  medical  or
    50  surgical  services  or  procedures that are deemed to be experimental in
    51  accordance with clinical guidelines referenced in  subparagraph  (F)  of
    52  this paragraph.
    53    (F)  The  superintendent,  in  consultation  with  the commissioner of
    54  health, shall promulgate regulations which shall  stipulate  the  guide-
    55  lines  and  standards which shall be used in carrying out the provisions
    56  of this paragraph, which shall include:

        A. 2415                             8
 
     1    (i) The determination of "infertility" in accordance with  the  stand-
     2  ards  and  guidelines established and adopted by the American College of
     3  Obstetricians and Gynecologists and the American Society  for  Reproduc-
     4  tive Medicine;
     5    (ii)  The identification of experimental procedures and treatments not
     6  covered for the diagnosis and treatment  of  infertility  determined  in
     7  accordance  with the standards and guidelines established and adopted by
     8  the American College of Obstetricians and Gynecologists and the American
     9  Society for Reproductive Medicine;
    10    (iii) The identification of  the  required  training,  experience  and
    11  other  standards  for  health care providers for the provision of proce-
    12  dures and treatments for the  diagnosis  and  treatment  of  infertility
    13  determined  in  accordance with the standards and guidelines established
    14  and adopted by the American College of Obstetricians  and  Gynecologists
    15  and the American Society for Reproductive Medicine; and
    16    (iv) The determination of appropriate medical candidates by the treat-
    17  ing  physician  in  accordance  with the standards and guidelines estab-
    18  lished and adopted by the American College of Obstetricians and Gynecol-
    19  ogists and/or the American Society for Reproductive Medicine.
    20    (G) A policy providing coverage under this  subsection  may  have  the
    21  following requirements and limitations:
    22    (I)  Limit coverage for in-vitro fertilization, gamete intra-fallopian
    23  transfer, zygote intra-fallopian transfer and low tubal ovum transfer to
    24  those individuals who have been unable to conceive or produce conception
    25  or sustain a successful pregnancy through less expensive  and  medically
    26  viable infertility treatment or procedures covered under such a policy.
    27    (II)  Nothing in this subsection shall be construed to deny the cover-
    28  age required by this section to any individual who forgoes a  particular
    29  infertility  treatment or procedure if the individual's physician deter-
    30  mines that such a treatment or procedure is likely to be unsuccessful;
    31    (III) Limit coverage to a lifetime cap of one hundred thousand dollars
    32  for ovulation induction, intrauterine insemination, in-vitro  fertiliza-
    33  tion,  intracytoplasmic  sperm  injection, uterine embryo lavage, embryo
    34  transfer, gamete intra-fallopian transfer, zygote intra-fallopian trans-
    35  fer, low tubal ovum transfer, donor eggs, and donor sperm;
    36    (IV) Require disclosure by the individual  seeking  such  coverage  to
    37  such  individual's  existing  health  insurance  carrier of any previous
    38  infertility treatment or procedures for which such  individual  received
    39  coverage  under  a  different  health  insurance policy. Such disclosure
    40  shall be made on a form and in the manner prescribed by the commissioner
    41  of the department of financial services.
    42    § 4. This act shall take effect immediately.
Go to top